Fundraising Fox
/Companies
Sign in

Aurenar

4 known investors

Find your way into Aurenar

Sign up to see every warm intro you have to Aurenar

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Aurenar team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Aurenar develops a non-invasive, ear-worn neuromodulation wearable that stimulates a nerve in the ear to boost the body's natural control of inflammation, targeting complications in intensive care unit patients. The device aims to improve patient outcomes, reduce hospital length of stay, and lower the cost of ICU care.

HardwareHealthtechMedical Devices

Founders & leadership

ELEric Leuthardt
Eric LeuthardtChief Executive Officer & FounderEric Leuthardt is a physician and neurotechnology innovator who holds numerous patents and publications in brain-computer interfaces and serves as director of the Center for Innovation in Neuroscience and Technology at Washington University School of Medicine. He has founded multiple neurotech companies, including NeuroLutions, and has experience spanning medical device development, academic research, and venture investment.
JGJenna Gorlewicz
Jenna GorlewiczChief Technology Officer & Founder
AHAnna Huguenard
Anna HuguenardChief Medical Officer & Founder
JWJesse Wheeler
Jesse WheelerChief Operations OfficerJesse Wheeler is Chief Operations Officer of Aurenar, which develops a non-invasive ear-worn neuromodulation device designed to modulate inflammation in intensive care patients. He brings cross-disciplinary experience in medtech business strategy, operations, regulatory affairs, and technical leadership spanning mechanical engineering, electronics, software development, and neuroscience.
RKRyan Kight
Ryan KightChief Financial OfficerChief Financial Officer of Aurenar, which develops a non-invasive ear-worn neuromodulation wearable designed to reduce inflammation in ICU patients. Kight has held senior financial leadership roles with experience in enterprise strategy, process optimization, and cross-functional team management.

Investors · 4

Kaleida Capitallisted by Kaleida CapitalSan Diegovia Ariane Tom · led
Solas BioVenturesreportedChattanooga

How we know: funding news · prnewswire.com · Not right? Tell us

Also in the syndicate · 1

Go Red for Women Venture Fund™lead

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

In the news

St. Louis startups secure millions in latest bioscience funding rounds | St. Louis Magazinestlmag.com · Aug 2026Aurenar Raises $5.7M in Seed Fundingfinsmes.com · Jul 2026

Frequently asked questions

What does Aurenar do?
Aurenar develops a non-invasive, ear-worn neuromodulation wearable that stimulates a nerve in the ear to boost the body's natural control of inflammation, targeting complications in intensive care unit patients. The device aims to improve patient outcomes, reduce hospital length of stay, and lower the cost of ICU care.
Who founded Aurenar?
Aurenar was founded by Eric Leuthardt, Jenna Gorlewicz, Anna Huguenard.
Who are Aurenar's investors?
Aurenar's investors include Deep Future, Kaleida Capital, Solas BioVentures.